Product Information
REZVOGLAR 100 UNIT/ML KWIKPEN is a brand biologic product labeled by Eli Lilly and Company, priced at $5.9195 per ML under NDC 00002898005. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
100 [iU]/mL
Manufacturer
Eli Lilly and CompanyNDC
00002898005
Classification
Brand Biologic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN GLARGINEApproval Type
Biologic (BLA)
FDA Application
BLA761215On Market Since
12/17/2021
Pharmacological Classes
Price Statistics
The NADAC for REZVOGLAR 100 UNIT/ML KWIKPEN has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.9195 per ML |
|---|---|
| All-time high | $5.9342 (Aug 13, 2025) |
| All-time low | $5.9188 (May 20, 2026) |
| 52-week high | $5.9342 |
| 52-week low | $5.9188 |
| Median price | $5.9253 |
| Average price | $5.9259 |
| Largest weekly change | -0.1% (Oct 22, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Insulin glargine-aglr market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of REZVOGLAR 100 UNIT/ML KWIKPEN?
The current National Average Drug Acquisition Cost (NADAC) for REZVOGLAR 100 UNIT/ML KWIKPEN, manufactured by Eli Lilly and Company, is $5.9195 per ML (NDC 00002898005), effective Jun 24, 2026.
How has the price of REZVOGLAR 100 UNIT/ML KWIKPEN changed over time?
Over the history we have for it, the NADAC for REZVOGLAR 100 UNIT/ML KWIKPEN has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for REZVOGLAR 100 UNIT/ML KWIKPEN?
Since Apr 17, 2024, the NADAC for REZVOGLAR 100 UNIT/ML KWIKPEN has ranged from a low of $5.9188 (May 20, 2026) to a high of $5.9342 (Aug 13, 2025), with a median of $5.9253 per ML.
Are there cheaper alternatives to REZVOGLAR 100 UNIT/ML KWIKPEN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of REZVOGLAR 100 UNIT/ML KWIKPEN, so no direct lower-cost alternative is listed.
Who manufactures REZVOGLAR 100 UNIT/ML KWIKPEN?
REZVOGLAR 100 UNIT/ML KWIKPEN (NDC 00002898005) is labeled by Eli Lilly and Company, and CMS classifies it as a brand biologic product.